Shaw J J, Lainson R
Trans R Soc Trop Med Hyg. 1975;69(3):323-35. doi: 10.1016/0035-9203(75)90127-3.
In spite of the difficulty of antigen standardization, paired intradermal skin tests demonstrated qualitative differences between leishmanin and in vitro exo-antigen. Some of these differences may be due to the destruction of certain antigens by phenol, while others seem to reflect basic antigenic differences. Leishmania mexicana amazonensis in vitro exo-antigen produced immediate anaphylactic reponses in 74.4% of the patients with parasitologically proven cutaneous leishmaniasis. Although more individuals responded to leishmanin, 82.4% as compared to 73.9%, the leishmanial in vitro exo-antigen gave significantly larger delayed responses, Trypanosoma cruzi trypamosomin elicited delayed reactions, while trypanosomal in vitro exo-antigen only produced immediate anaphylactic reactions in persons with active cutaneous leishmaniasis.
尽管抗原标准化存在困难,但配对皮内皮肤试验显示利什曼原虫素与体外外抗原之间存在质的差异。其中一些差异可能是由于某些抗原被苯酚破坏,而其他差异似乎反映了基本的抗原差异。墨西哥利什曼原虫亚马逊亚种体外外抗原在74.4%经寄生虫学证实的皮肤利什曼病患者中产生即刻过敏反应。尽管有更多个体对利什曼原虫素产生反应,分别为82.4%和73.9%,但利什曼原虫体外外抗原产生的迟发反应明显更大。克氏锥虫锥虫素引发迟发反应,而锥虫体外外抗原仅在活动性皮肤利什曼病患者中产生即刻过敏反应。